|
Wissenschaftliche Publikationen
Originalarbeiten in wissenschaftlichen
Fachzeitschriften:
- Arab A, Grumann T, Guttenberger R, Bode C, Hehrlein C: Reoxygenation of hypoxic coronary smooth muscle cells amplifies growth-retarding effects of ionizing irradiation. Circulation, 2004; 109 (8): 1036-1040.
- Bartelt S, Momm F, Weissenberger Ch, Lutterbach J: Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: Prognostic factors and survival World J Gastroentero, 2004; 12 (22): 3345-3348.
- Brink I, Schumacher T, Mix M, Ruhland S, Stoelben E, Digel W, Henke M, Ghanems N, Moser E, Nitzsche EU: Impact of [(18)F] FDG-PET on the primary staging of small-cell lung cancer Eur J Nucl Med Mol I, 2004. (in Druck)
- Brunner T, Johr M: Anesthetic management of a child with xeroderma pigmentosum. Paediatr Anaesth, 2004; 14 (8): 697-698. : http://dx.doi.org/10.1111/j.1460-9592.2004.01367.x
- Brunner T, Martin SJ: c-Myc: where death and division collide. Cell Cycle, 2004; 3 (4): 456-459.
- Brunner TB, Hahn SM, McKenna WG, Bernhard EJ: Radiation sensitization by inhibition of activated Ras. Strahlenther Onkol, 2004; 180 (11): 731-740. : http://dx.doi.org/10.1007/s00066-004-9198-8
- Brunner TB, Schwab D, Meyer T, Sauer R: Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysis. Strahlenther Onkol, 2004; 180 (12): 751-757. : http://dx.doi.org/10.1007/s00066-004-1315-1
- Cima I, Corazza N, Dick B, Fuhrer A, Herren S, Jakob S, Ayuni E, Mueller C, Brunner T: Intestinal epithelial cells synthesize glucocorticoids and regulate T cell activation. J Exp Med, 2004; 200 (12): 1635-1646. : http://dx.doi.org/10.1084/jem.20031958
- Corazza N, Brumatti G, Jakob S, Villunger A, Brunner T: TRAIL and thymocyte apoptosis: not so deadly? Cell Death Differ, 2004; 11 Suppl 2: S213-S215. : http://dx.doi.org/10.1038/sj.cdd.4401525
- Corazza N, Brumatti G, Schaer C, Cima I, Wasem C, Brunner T: TRAIL and immunity: more than a license to kill tumor cells. Cell Death Differ, 2004; 11 Suppl 2: S122-S125. : http://dx.doi.org/10.1038/sj.cdd.4401542
- Corazza N, Brunner T, Buri C, Rihs S, Imboden MA, Seibold I, Mueller C: Transmembrane tumor necrosis factor is a potent inducer of colitis even in the absence of its secreted form. Gastroenterology, 2004; 127 (3): 816-825.
- Engler OB, Schwendener RA, Dai WJ, Wolk B, Pichler W, Moradpour D, Brunner T, Cerny A: A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins. Vaccine, 2004; 23 (1): 58-68. : http://dx.doi.org/10.1016/j.vaccine.2004.05.009
- Fritzsche K, Liptai C, Henke M: Psychosocial distress and need for psychotherapeutic treatment in cancer patients undergoing radiotherapy Radiother Oncol, 2004; 72: 183-189.
- Henke M: Erythropoietin and Curative Cancer Treatment. The American Journal of Oncology Review, 2004; 3 (4): 190-192.
- Henke M, Laszig R, Frommhold H: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet, 2004; 363 (9402): 81-82.
- Henke M, Pajonk F: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet, 2004; 363 (9413): 993-993.
- Henke M, Sindlinger F, Ikenberg H, Gerds T, Schumacher M: Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol, 2004; 180 (1): 45-51.
- Kortmann RD, Jeremic B, Weller M, Lutterbach J, Paulsen F, Bamberg M: Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma? Strahlenther Onkol, 2004; 180 (7): 408-418.
- Lutterbach J, Weissenberger C, Hitzer K, Helmes A: [On past practices and future directions of informed consent in (radiation) oncology] Strahlenther Onkol, 2004; 180 (8): 469-477.
- Martin NE, Brunner TB, Kiel KD, DeLaney TF, Regine WF, Mohiuddin M, Rosato EF, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, Tanaka WK, Morrison B, Deutsch P, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ, Hahn SM: A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer. Clin Cancer Res, 2004; 10 (16): 5447-5454. : http://dx.doi.org/10.1158/1078-0432.CCR-04-0248
- McBride WH, Chiang CS, Olson J, Wang CC, Hong JH, Pajonk F, Dougherty G, Iwamoto K, Pervan M, Liao YP: A Sense of Danger from Radiation Radiat Res, 2004; 162 (1): 1-19.
- Momm F, Becker G, Bartelt S, Guttenberger R: The old, fragile tumour patient: radiotherapy as a most effective and most feasible palliative treatment modality. J Pain Symptom Manag, 2004; 27 (1): 3-4.
- Momm F, Becker G, Ewald H, Baumgartner J, Adamietz IA, Frommhold H: Strahlentherapeutische Beteiligung an interdisziplinären palliativmedizinischen Einrichtungen - Herausforderung und Chance. Strahlenther Onkol, 2004; 180 (2): 73-77.
- Pajonk F, Scholber UJ, Fiebich B: Inhibition of Proteasome Function Contributes to Effects and Side-Effects of Hypericin Cancer Chemoth Pharm, 2004. (in Druck)
- Pajonk F, Weil A, Sommer A, Suwinksi R, Henke M: The Erythropoietin-ReceptorPathway Modulates Survival of Cancer Cells Oncogene, 2004. (in Druck)
- Schipper J, Henke M: Erythropoietin in patients with head and neck carcinomas? Laryngo Rhino Otol, 2004; 83 (5): 292-297.
- Schreiber FS, Deramaudt TB, Brunner TB, Boretti MI, Gooch KJ, Stoffers DA, Bernhard EJ, Rustgi AK: Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene. Gastroenterology, 2004; 127 (1): 250-260.
- Schulze-Bonhage A, , Lutterbach J, , Ostertag C: Diagnostik und Therapie bei gelastischen Epilepsien Z Epileptol, 2004; 17: 279-286.
- Torgler R, Jakob S, Ontsouka E, Nachbur U, Mueller C, Green DR, Brunner T: Regulation of activation-induced Fas (CD95/Apo-1) ligand expression in T cells by the cyclin B1/Cdk1 complex. J Biol Chem, 2004; 279 (36): 37334-37342. : http://dx.doi.org/10.1074/jbc.M406913200
- Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R, Pajak TF, Fleming TR, Henke M, Bourhis J, Rosenthal DI, Junor E, Cmelak A, Sheehan F, Pulliam J, Devitt-Risse P, Fuchs H, Chambers M, O'Sullivan B, Ang KK: A multinational, randomized phase III trial of iseganan hcl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck-malignancy. Int J Radiat Oncol, 2004; 58 (3): 674-681.
- Weissenberger C, Jonassen S, Beranek-Chiu J, Neumann M, Muller D, Bartelt S, Schulz S, Monting JS, Henne K, Gitsch G, Witucki G: Breast cancer: patient information needs reflected in English and German web sites. Brit J Cancer, 2004; 91 (8): 1482-1487.
- Wiener Z, Ontsouka EC, Jakob S, Torgler R, Falus A, Mueller C, Brunner T: Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells. Exp Cell Res, 2004; 299 (1): 227-235. : http://dx.doi.org/10.1016/j.yexcr.2004.05.031
|